FIGURE

Fig. 2

ID

ZDB-FIG-191120-2

Publication

Ibhazehiebo et al., 2018 - A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target

Other Figures

All Figure Page

Back to All Figure Page

Fig. 2

ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	TL TL + MO1-kcna1a + MO4-tp53
Conditions:	chemical treatment by environment: pentetrazol chemical treatment by environment: levetiracetam chemical treatment by environment: tiagabine chemical treatment by environment: topiramate chemical treatment by environment: pentetrazol constant dark chemical treatment by environment: eslicarbazepine acetate, constant dark chemical treatment by environment: primidone, constant dark chemical treatment by environment: rufinamide, constant dark
Knockdown Reagents:	MO1-kcna1a MO4-tp53
Observed In:	cellular respiration oxidative phosphorylation
Stage:	Long-pec

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Brain